GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by WR Wealth Planners LLC

WR Wealth Planners LLC trimmed its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 10.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 9,124 shares of the company’s stock after selling 1,064 shares during the quarter. WR Wealth Planners LLC’s holdings in GE HealthCare Technologies were worth $713,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. Mesirow Financial Investment Management Inc. raised its position in shares of GE HealthCare Technologies by 39.6% during the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 4,084 shares of the company’s stock worth $383,000 after purchasing an additional 1,159 shares during the period. Cathy Pareto & Associates Inc. bought a new position in GE HealthCare Technologies in the 4th quarter worth approximately $670,000. LMR Partners LLP bought a new position in GE HealthCare Technologies in the 3rd quarter worth approximately $7,387,000. Principal Financial Group Inc. grew its holdings in GE HealthCare Technologies by 1.9% in the 3rd quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company’s stock worth $94,780,000 after buying an additional 19,010 shares in the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG bought a new position in GE HealthCare Technologies in the 3rd quarter worth approximately $1,396,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on GEHC. Wells Fargo & Company increased their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. Citigroup increased their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. Finally, Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price objective for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $97.67.

GE HealthCare Technologies Stock Performance

GEHC opened at $87.35 on Friday. The firm has a market cap of $39.94 billion, a PE ratio of 20.17, a P/E/G ratio of 3.19 and a beta of 1.15. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The business has a fifty day simple moving average of $86.17 and a 200-day simple moving average of $86.10. GE HealthCare Technologies Inc. has a fifty-two week low of $74.51 and a fifty-two week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.19. The business had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. As a group, equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.